The largest database of trusted experimental protocols

Mir 23a 3p inhibitor

Manufactured by GenePharma
Sourced in United States, China

The MiR-23a-3p inhibitor is a laboratory tool used to modulate the expression of the miR-23a-3p microRNA. It is designed to inhibit the activity of this specific microRNA in experimental settings.

Automatically generated - may contain errors

3 protocols using mir 23a 3p inhibitor

1

Lentiviral miR-23a-3p Overexpression in BMSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Synthetic miR-23a-3p mimic (sequence: 5′-ATCACATTGCCAGGGATTTCC-3′), miR-23a-3p inhibitor (sequence: 5′-GGAAATCCCTGGCAATGTGAT-3′) and negative control (NC, sequence: 5′-TTCTCCGAACGTGTCACGTTTC-3′) were purchased from GenePharma (Sunnyvale, CA, USA) along with lentiviral green fluorescent protein (GFP)-tagged vector LV3-pGLV-h1-GFP-puro. The synthetic mRNA (1×109 transducing units/ml) was transfected into BMSCs according to the manufacturer's protocol. The most effective multiplicity of infection (MOI) was decided according to the pilot experiment (data not shown). rBMSCs were plated onto 10 cm dishes at a density of 1×106 cells/dish in 5 ml media and transfected using a GFP-tagged lentiviral vector (lenti-23a-mimic-GFP, lenti-23a-inhibitor-GFP and lenti-GFP) at an MOI of 100 plaque-forming unit/cell in the presence of 5 µl polybrene (Merck KGaA). Fresh media was added at 24 h following transfection. Transfection efficiency was analyzed by calculating the number of GFP tagged cells out of the total number of cells after 72–96 h following transfection. The BMSCs was imaged under a fluorescence microscope (×200). Transfection rate was measured by flow cytometry (9 (link)) (Fig. 2). The BMSCs of the rats were isolated and cultured under standard conditions. The transfection rate was >95%.
+ Open protocol
+ Expand
2

Modulating miRNA and Protein Regulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
After LPS treatment, MLE-12 cells were reaped at logarithmic growth phase and seeded into 6-well plates (1 × 106 cells/well). After cell confluence had reached 80–90%, cells were transfected with the indicated plasmids for 48 h, in the presence of lipofectamine 3000 kit (Invitrogen). The miR-182-5p mimics, miR-182-5p inhibitor and miR-23a-3p mimics, miR-23a-3p inhibitor were constructed by GenePharma (Shanghai, China) along with their corresponding NCs. To silence Dicer expression, the specific shRNA to Dicer was synthesized by GenePharma. In addition, the full-length cDNA sequences of Usp5, Ikbkb, and p65 were individually inserted into the pcDNA3.1 vectors (Invitrogen) for overexpression.
+ Open protocol
+ Expand
3

Regulating MALAT1 and miR-23a-3p in HK-2 cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MALAT1 siRNA, MALAT1 siRNA NC, MALAT1 over-expression plasmid, miR-23a-3p mimic, miR-23a-3p inhibitor and the negative control were purchased from GenePharma (Shanghai, China). HK-2 cells were transfected by MALAT1 siRNA with or without miR-23a-3p inhibitor using Lipofectamine 3000 (Invitrogen) according to the protocol of the manufacturer.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!